TAVI Reimbursement Expansion for Low- and Inter...

By João L. Carapinha

March 19, 2026

The TAVI reimbursement expansion announced by Zorginstituut Nederland on March 10, 2026, includes...
EU Approves Imfinzi Gastric Cancer Treatment as Perioperative Immunotherapy
FDA Biosimilar Approval Reforms: Accelerating Access and Reducing Drug Costs
FDA Warning Letter Novo Nordisk Reveals Serious Compliance Failures in Advers...
Methodological Gaps in Economic Evaluations of Vaccines: A Systematic Review
Rapid Genetic Testing Mitigates Gentamicin-Induced Hearing Loss in Neonates
Urgent Call for Enhanced Precision Oncology Access in Europe
Tirzepatide Cost Effectiveness: A Winning Strategy for Type 2 Diabetes Manage...
EMA’s mCombriax Vaccine Recommendation
HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 T...
Novo Nordisk Announces Semaglutide Price Reduction to Improve Patient Access
NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement